References
- Creager M. A., Dzau V. J. “Neurohormonal Mechanisms in Heart Failure,”. Heart Failure 1986; 2: 3
- Dzau V. J., Hollenberg N. K., Williams G. H. “Neurohormonal mechanism in heart failure. Role in pathogenesis, therapy and drug tolerance,”. Fed. Proc. 1983; 42: 3162
- Levine T. B., Francis G. S., Goldsmith S. R., Simon A. B., Cohn J. N. “Activity of the sympathetic nervous system and the renim-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure,”. Am. J. Cardiol. 1982; 49: 1659
- Dzau V. J., Packer M., Swartz S. L., Lilly L. S., Hollenberg N.O. K., Williams G. H. “Prostaglandins in heart failure: relationship to renin-angiotensin system and hyponatremia,”. N. Engl. J. Med. 1984; 310: 347
- Packer M., Medina N, Yushak M. “Relation between serum sodium concentration and the hemodynamic and clinical responses to converting enzyme inhibition with captopril in severe heart failure,”. J. Am. Col. Cardiol. 1984; 3: 1521
- Creager M. A., Dzau V. J. “Prostaglandins in congestive heart failure,”. The Renin Angiotensin System, J. I. S. Robertson, M. G. Nicholls. Gower Publishers, London 1986
- Creager M. A., Halperin J. L., Bernard D. B., Faxon D. P., Melidossian C. D., Gavras H., Ryan T. J. “Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure,”. Circulation 1981; 64: 483
- Rajagopalan B., Raine A. E. G., Cooper R., Ledingham J. C. G. “Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment,”. Am. J. Med. 1984; 76(5B)86
- Paulson O. B., Jarden J. O., Godtfredsen J., Vorstrup S. “Cerebral blood flow in patients with congestive heart failure treated with captopril,”. Am. J. Med. 1984; 76(5B)91
- Chatterjee K., Rouleau J.-L., Parmley W. W. “Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure,”. Br. Heart J. 1982; 47: 233
- Ertl G., Kloner R. A., Alexander R. W., Braunwald E. “Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor,”. Circulation 1982; 65: 40
- Daly P., Mettauer B., Rouleau J.- L., Cousineau D., Burgess J. H. “Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect,”. Circulation 1985; 71: 317
- Dzau V. J., Hollenberg N. K. “Renal response to captopril in severe heart failure: role of furosemide in natriuresis and reversal of hyponatremia,”. Ann. Intern. Med. 1984; 100: 777
- Dzau V. J., Colucci V. S., Williams G. H, Curfman G., Meggs L., Hollenberg N. K. “Sustained effectivenesas of converting enzyme inhibition in patients with severe congestive heart failure,”. N. Engl. J. Med. 1980; 302: 1373
- Sharpe D. N. “The therapeutic use of angiotensin converting eznyme (ACE) inhibitors in cardiac failure: long term efficacy and comparison with other vasodilators,”. The Renin Angiotensin System, J. I. S. Robertson, M. G. Nicholls. Gower Publishers, London 1986
- Captopril Multicenter Research Group. “A placebo-controlled trial of captopril in refractory chronic congestive heart failure,”. J. Am. Coll. Cardiol. 1983; 2: 755
- Cleland J. G. F., Dargie H. J., Hodsman G. P., Bali S. G., Robertson J. I. S., Murray G. D., Gillen G. “A controlled trial of enalapril in cardiac failure. Br. Heart J. 1985; 54: 305
- Sharpe D. N., Murphy J., Coxon R., Hannan S. F. “Enalapril in chronic heart failure: a placebo-controlled, randomised, double-blind study,”. Circulation 1983; 70: 271
- Packer M., Medina N, Yushak M., Meller J. “Haemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure,”. Circulation 1983; 68: 803
- Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. “Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure,”. N. Engl J. Med. 1984; 311: 819
- Lee W. H., Packer M. “Congestive heart failure: Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure,”. Circulation 1986; 73: 257
- Furberg C D., Yusuf S. “Effect of vasodilators on survival in chronic congestive heart failure,”. Am. J. Cardiol. 1985; 55: 1110
- Cleland J. G. F., Dargie H. J., Hosman G. P., Ball S. G., Robertson J. I. S., Murray G. D., Gillen G. “Captopril in heart failure: a double-blind controlled trial,”. Br. Heart J. 1984; 52: 530